Abstract
Radioligand binding studies were performed in membranes of rat cerebellum using [125I]-[Tyr3]octreotide ([125I]204-090) to characterize the nature of cerebellar somatostatin receptors. Saturation experiments suggest the presence of a single class of binding sites with high affinity, pKd = 9.53 ± 0.11, but low receptor density, B max = 12.7 ± 1.0 fmol/mg protein. The pharmacological profile of [125I]204-090 sites in cerebellar membranes was established using a range of ligands known to interact with SSTR-2 (now called sst2) and other somatostatin (SRIF) receptors. SRIF analogues such as octreotide (SMS 201-995), seglitide (MK 678) and somatuline (BIM 23014) displayed very high affinity for cerebellar [125I]204-090 binding sites. The data were compared to results obtained using the same ligand in rat cerebral cortex membranes known to represent sst2 binding. The pharmacological characteristics of the cerebellar sites were in close correlation with those of the cerebral cortex (r = 0.976, n = 19, p < 0.001) and CHO-cells expressing human recombinant sst2 receptor (r = 0.977, n = 19, p < 0.001). By contrast, there was very little correlation between cerebellar binding and published affinities for rat sst5 receptors (r = 0.465), for which octreotide has also high affinity. In vitro autoradiographic studies performed in cerebellar slices using [125I]204-090 demonstrated the presence of binding sites in the molecular layer of the rat cerebellum. In situ hybridization studies using sst2 receptor mRNA selective oligoprobes confirmed the presence of sst2 receptor mRNA in the rat cerebellum. Together, the present data demonstrate the presence of a low density of SRIF receptors in the molecular layer of the adult rat cerebellum which are best characterized as sst2. This is the first pharmacological characterization and localization of sst2 receptors in the adult rat cerebellum.
Similar content being viewed by others
References
Bell GI, Reisine T (1993) Molecular biology of somatostatin receptors. TiNS 16:34–38
Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254
Bruno JF, Xu Y, Song J, Berelowitz M (1993) Tissue distribution of somatostatin receptor subtype messenger ribonucleic acid in the rat. Endocrinology 133:2561–2567
Bucharles C, Vaudry H, Leroux P (1994) Pharmacological characterization of somatostatin receptors in rat cerebellar nuclei. Eur J Pharmacol 271:79–86
Buscail L, Estève JP, Prats H, Bayard F, Bell GI, Vaysse N, Susini C (1993) Human somatostatin receptor hSSTR-2 may mediate the antiproliferative effect of octreotide. Gastroenterology 104:816
Epelbaum J, Dournaud P, Fodor M and Viollet C (1994) The neurobiology of somatostatin. Crit Rev Neurobiol 8:25–44
Feniuk W, Dimech J, Humphrey PPA (1993) Characterization of somatostatin receptors in guinea-pig isolated ileum, vas deferens and right atrium. Br J Pharmacol 110:154–157
Hoyer D, Engel G, Kalkman HO (1985) Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (−)[125I]iodocyanopindolol, [3H]mesulergine and [3H] ketanserin. Fur J Pharmacol 18:13–23
Hoyer D, Lübbert H, Bruns C (1994) Molecular pharmacology of somatostatin receptors. Naunyn-Schmiedeberg's Arch Pharmacol 350:441–453
Hoyer D, Pérez J, Schoeffter P, Langenegger D, Schüpbach E, Kaupmann K, Lübbert H, Bruns C, Reubi JC (1995a) Pharmacological identity between somatostatin SS-2 binding sites and SSTR-1 receptors. Fur J Pharmacol 289:151–161
Hoyer D, Bell GI, Berelowitz M, Epelbaum J, Feniuk W, Humphrey PPA, O'Carroll AM, Patel YC, Schonbrunn A, Taylor JE, Reisine T (1995b) Classification and nomenclature of somatostatin receptors. TiPS 16:86–88.
Kaupmann K, Bruns C, Hoyer D, Seuwen K, Lübbert H (1993) Distribution and second messenger coupling of four somatostatin receptor subtypes expressed in brain. FEBS Lett 331:53–59
Koch BD, Dorflinger LJ, Schonbrunn A (1985) Pertussis toxin blocks both cyclic AMP-mediated and cyclic AMP-independent action of somatostatin. J Biol Chem 260:13138–13145
Laquerrière A, Leroux P, Gonzalez BJ, Bodenant C, Tajot J, Vaudry H (1992) Somatostatin receptors in the human cerebellum during development. Brain Res 573:251–259
Laquerrière A, Leroux P, Bodenant C, Gonzalez BJ, Tajot J, Vaudry H (1994) Quantitative autoradiographic study of somatostatin receptors in the adult human cerebellum. Neuroscience 62:1147–1154
Martin JL, Chesselet MF, Raynor K, Gonzales C, Reisine T (1991) Differential distribution of somatostatin receptor subtypes in rat brain revealed by newly developed somatostatin analogs. Neuroscience 41:581–593
McKeen ES, Feniuk W, Humphrey PPA (1994) Mediation by SRIF-1 receptors of the contractile- action of somatostatin in rat isolated distal colon: studies using some novel SRIF analogues. Br J Pharmacol 113:628–634
O'Carroll AM, Raynor K, Reisine T (1994) Characterization of cloned human somatostatin receptor SSTR5. Mol Pharmacol 46:291–298.
Pazos A, Hoyer D, Palacios JM (1984) The binding of serotonergic ligand to the porcine choroid plexus: characterization of a new type of serotonin recognition site. Fur J Pharmacol 106:539–546
Pérez J, Hoyer D (1995) Coexpression of somatostatin SSTR-4 and SSTR-3 receptor mRNAs in the rat central nervous system. Neuroscience 64:241–253
Pérez J, Rigo M, Kaupmann K, Bruns C, Yasuda K, Bell GI, Lübbert H, Hoyer D (1994) Localization of somatostatin (SRIF) SSTR-1, SSTR-2 and SSTR-3 receptor mRNA in rat brain by in situ hybridization. Naunyn-Schmiedeberg's Arch Pharmacol 349:145–160
Raynor K, O'Carroll AM, Kong H, Yasuda K, Mahan LC, Bell G, Reisine T (1993) Characterization of cloned somatostatin receptors SSTR4 and SSTR5. Mol Pharmacol 44:385–392
Reichlin S (1983) Somatostatin. N Engl J Med 309:1495–1505 1556–1563
Reubi JC (1985) New specific radioligand for one subpopulation of brain somatostatin receptors. Life Sci 36:1829–1836
Reubi JC, Cortès R, Maurer R, Probst A, Palacios JM (1986) Distribution of somatostatin receptors in the human brain, an autoradiographic study. Neuroscience 18:329–346
Schoeffter P, Pérez J, Langenegger D, Schüpbach E, Lübbert H, Bruns C, Hoyer D (1995) Characterization and distribution of somatostatin SS-1 and SRIF-1 binding sites in rat brain: identity with SSTR-2 receptors. Eur J Pharmacol 289:163–173
Schloos J, Raulf F, Engel G, Hoyer D, Bruns C (1995) Identification and characterization of somatostatin receptors in rat lung tissue. Br J Pharmacol 114:49P
Senaris RM, Humphrey PPA, Emson PC (1994) Distribution of somatostatin receptors 1, 2 and 3 mRNA in rat brain and pituitary. Eur J Neurosci 6:1883–1896
Uhl GR, Tran V, Snyder SH, Martin JB (1985) Somatostatin receptors: distribution in rat central nervous system and human frontal cortex. J Comp Neurol 240:228–304
Vilaro MT, Wiederhold KH, Palacios JM, Mengod G (1992) Muscarinic M2 receptor mRNA expression and receptor binding in cholinergic and non-cholinergic cells in the rat brain: a correlative study using in situ hybridization histochemistry and receptor autoradiography. Neuroscience 47:367–393
Wulfsen I, Meyerhof W, Fehr S, Richter D (1993) Expression patterns of rat somatostatin genes in pre- and postnatal brain and pituitary. J Neurochem 61:1549–1552
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Piwko, C., Silke Thoss, V. & Hoyer, D. Localization and pharmacological characterization of somatostatin sst2 sites in the rat cerebellum. Naunyn-Schmiedeberg's Arch Pharmacol 352, 607–613 (1995). https://doi.org/10.1007/BF00171318
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00171318